A resolution designating May 2026 as "National Brain Tumor Awareness Month".
S. Res. 746 is a simple Senate resolution that designates May 2026 as “National Brain Tumor Awareness Month.” The resolution recites findings about the prevalence and severity of brain tumors in the United States, including the number of expected diagnoses and deaths, the especially serious impact on children, teens, and young adults, and the limited treatment options and research progress to date. It frames the month as a time for nationwide awareness, outreach, and advocacy.
The resolution also states the Senate’s support for people living with brain tumors, those who have died from them, and their families, friends, and caregivers. It encourages public awareness, supports efforts to develop better treatments, and urges a collaborative approach to research as a way to improve understanding and outcomes. Because it is a resolution, it does not create a regulatory program or direct spending; it is primarily commemorative and expressive in nature.
The resolution does not amend the U.S. Code or change state law; it is a nonbinding Senate designation recognizing a month of awareness. Its practical effect is to encourage public education, advocacy, and research attention around brain tumors, while signaling congressional support for patients, caregivers, and medical research efforts. No statutes are directly affected, and no enforcement or administrative obligations are created.
The bill appears to have been received very positively and without controversy. It was agreed to by unanimous consent, without amendment, indicating broad bipartisan support and little to no opposition. The tone of the resolution is sympathetic and supportive, emphasizing awareness, research, and solidarity with affected individuals and families.
There is no notable recorded contention in the available materials. The resolution’s findings highlight the seriousness of brain tumors and the need for better treatments, but these points are presented as shared concerns rather than disputed issues. Because the measure is commemorative and nonbinding, it does not appear to have raised policy disagreements over funding, regulation, or implementation.